A Phase 3 Trial of Lesion Network Mapping-Guided cTBS for Motor Recovery After Acute Ischemic Stroke
A phase 3 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 584 participants.
Also called NCT07645586
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 584 participants
- Sponsor
- Registry
-
NCT07645586
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Not yet recruiting
Technical summary
Registry record NCT07645586. Randomized; quadruple masking; primary purpose treatment. Start 2026-10-01 (anticipated); primary completion 2027-09-30 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Phase 3 Trial of Lesion Network Mapping-Guided cTBS for Motor Recovery After Acute Ischemic Stroke
- Acronym
- MASTRE-3
- Condition
- Ischemic Stroke
- Intervention (Device)
- LNM-navigated cTBS
- Intervention (Device)
- Sham cTBS
- Lead sponsor
- Beijing Tiantan Hospital
Record details
- Record id
cardio:ct-nct07645586- Content hash
ce3c120bbd0174cc22827361798463bb16d50195f6257821ec09b969acf9bed7